Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation

被引:21
作者
Bourne, Richard S. [1 ,2 ]
Dorward, Ben J. [3 ]
机构
[1] No Gen Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Pharm, Sheffield S5 7AU, S Yorkshire, England
[2] No Gen Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Crit Care, Sheffield S5 7AU, S Yorkshire, England
[3] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Pharm, Sheffield S10 2JU, S Yorkshire, England
关键词
Clinical pharmacist; Critical care; Medication errors; Neurosurgery; United Kingdom; ERRORS; IMPACT; COST;
D O I
10.1007/s11096-011-9538-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective To identify the input of specialist critical care pharmacists into patient care, promoting safe and effective medication therapy by quantifying medicines related interventions on a Neurocritical Care Unit. Setting UK 19-bedded Neurocritical Care Unit providing a tertiary referral service for Neurosurgical and Neurology patients. Method Prospective observational study of clinical pharmacist interventions conducted over a 2 week period in July 2010. Interventions were recorded, categorised and independently assessed by a panel of 5 healthcare professionals for potential patient harm if the intervention had not been made. Main outcome measure Quantity and potential severity of clinical pharmacist interventions recorded. Results 246 interventions were made in 55 patients over the 10 day observational period. A median of 7.0 (1.5; 12.0) and 2.0 (1.0; 4.0) interventions were made in Level 3 and 2 patients respectively. Mean potential severity of patient harm per intervention was 3.7 (1.12); range 0.8-7.0. Central Nervous System medicines comprised the most common therapeutic group affected (37.8%). Medication errors accounted for 87 of the 246 interventions (35.4%). Conclusion The results of the clinical pharmacist intervention evaluation demonstrated an important role for critical care pharmacists in the safe and effective use of medicines in a UK Neurocritical care unit.
引用
收藏
页码:755 / 758
页数:4
相关论文
共 10 条
[1]  
Al-Jazairi AS, 2008, SAUDI MED J, V29, P277
[2]  
Allied health professionals and health care scientists, 2003, ALL HLTH PROF HLTH C
[3]  
[Anonymous], BEST MED MAN MED AC
[4]   A validated, reliable method of scoring the severity of medication errors [J].
Dean, BS ;
Barber, ND .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (01) :57-62
[5]  
Department of Health, 2005, AD CRIT CAR SPEC PHA
[6]  
Intensive Care Society, 2009, Intensive Care Soc Joint descriptive document
[7]   Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist [J].
Kopp, Brian J. ;
Mrsan, Melinda ;
Erstad, Brian L. ;
Duby, Jeremiah J. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (23) :2483-2487
[8]  
Saokaew Surasak, 2009, Pharmacy Pract (Granada), V7, P81
[9]   Errors in administration of parenteral drugs in intensive care units: multinational prospective study [J].
Valentin, Andreas ;
Capuzzo, Maurizia ;
Guidet, Bertrand ;
Moreno, Rui ;
Metnitz, Barbara ;
Bauer, Peter ;
Metnitz, Philipp .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 :928-931
[10]   Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital [J].
Zaidi, STR ;
Hassan, Y ;
Postma, MJ ;
Ng, SH .
PHARMACY WORLD & SCIENCE, 2003, 25 (06) :299-302